2017 Philadelphia

Going Beyond with Non-Traditional Data Sources and Data Driven Analytics

Sunday, April 02, 2017 – Tuesday, April 04, 2017, Loews Philadelphia

Keynote

Challenges and Opportunities for the Future

William S. Hayes, PhD

Vice President of Data Science, Applied Dynamic Solutions

William Hayes, PhD Molecular Biology and Bachelors in Aerospace Engineering from Georgia Tech, is the VP of Data Science at Applied Dynamic Solutions, helping partners find more effective solutions to the big data and information heavy problems facing healthcare, bioPharma and other industries.

He was previously the CTO of Selventa (a personalized healthcare company using Systems Biology and OpenBEL for diagnostics development), Director of Decision Support in Biogen Idea R&D IT, Head of the Library & Literature Informatics Dept at Biogen Idea, and Head of Cross-Discovery Strategic Informatics at AstraZeneca focusing on data/text/image mining technologies and knowledge management. Prior to that he was the Bioinformatics project lead for drug target-focused Text Mining. The expertise in text mining grew out of frustration with large-scale gene promoter analysis projects he performed at GlaxoSmithKline (GSK) where time in the library finding support for computational analyses took over 40X the time it took to run the computational part of the analyses. Due to his experience at abusing supercomputing resources from rather large sequence analysis and other computationally intensive projects, he has also been very active in big data, semantic technologies, distributed computing and cloud computing. His background in Aerospace Engineering and structural engineering of jet engines gives him an unusual viewpoint into computational molecular biology and a broad perspective on technical challenges and how to solve them.

Continuing Education Course

Workshop: Overcoming Copyright Complexities in the Biopharmaceutical Industry

Michele L. Ayers and Stephen K. Garfield

Scientific content plays an important role in the business process of a biopharmaceutical corporation from the discovery research stage all the way to post-marketing pharmacovigilance, plus medical communication/information for marketing purposes, and occasionally even product liability litigation. Journal articles, reference books, treatment guidelines, conference abstracts and posters, etc. all need to be readily available for all employees. Awareness of the copyright implication and the best practices in content use and reuse are important factors in making appropriate decisions around the use of copyright protected materials. With an emphasis on all types of scientific content, key issues that affect employees are discussed. During the workshop, participants will have the opportunity to participate in a Q & A session as well as other interactive exercises. They will also receive a workbook to help with copyright questions long after the workshop has been completed.

Workshop Features:

1. What is and is not copyright-protected?

2. Fair use in a corporate environment

3. When copyright permission is needed and how to obtain it?

5. Social media concerns

6. Issues specific to the biopharmaceutical industry including open access and text and data mining

Who Should Attend?

Biopharmaceutical professionals at all organization levels and anyone who wants to gain a better understanding of copyright law as applicable in a biopharmaceutical setting.

Michele L. Ayers, Senior Manager, Educational Services

Michele leads Copyright Clearance Center’s educational programs from development to delivery. Through Copyright Clearance Center’s courses, webinars and events, thousands have improved their understanding of copyright and compliance best practices. Michele is an invited speaker and educator on copyright law at companies and events worldwide. Since joining Copyright Clearance Center in 1999, Michele has developed a deep appreciation of the concerns and needs of content providers and users worldwide.

Stephen K. Garfield, Sr. Director, Client Engagement

Stephen Garfield joined CCC in 2005 and is the Sr. Director Client Engagement. In this role, he has the dual responsibility for the annual renewals of all CCC’s corporate copyright and software licenses, as well as overseeing Strategic Client Engagement. Together, these two roles give Stephen the opportunity to meet with and best understand customer needs and objectives to help drive future relationships in the corporate market.

Prior to joining CCC, Stephen spent eight years at Dow Jones as the Regional Manager, New England and Eastern Canada, of The Wall Street Journal, and 13 years at McGraw-Hill publishing working on Aviation Week & Space Technology magazine.